- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.10. | Cannara Biotech Inc (2): Cannara Biotech approved for DTC electronic clearing | 2 | Stockwatch | ||
| 07.10. | Cannara Biotech Inc.: Cannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity Conversion | 140 | GlobeNewswire (Europe) | MONTREAL, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade... ► Artikel lesen | |
| 03.10. | Cannara Biotech Inc (2): Cannara Biotech to issue 3.46 million shares for debt | 7 | Stockwatch | ||
| 03.10. | Cannara Biotech Inc (2): Cannara Biotech shares for debt | 2 | Stockwatch | ||
| 02.10. | Cannara Biotech Inc.: Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance | 5 | GlobeNewswire (USA) | ||
| 01.09. | Cannara Biotech Inc.: Cannara Announces Grant of Options and RSUs | 1 | GlobeNewswire (USA) | ||
| CANNARA BIOTECH Aktie jetzt für 0€ handeln | |||||
| 21.08. | Cannara Biotech Inc (2): Cannara adds $10-million credit facility with BMO | 4 | Stockwatch | ||
| 21.08. | Cannara Biotech Inc.: Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield | 244 | GlobeNewswire (Europe) | MONTREAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade... ► Artikel lesen | |
| 14.08. | Cannara Biotech Inc (2): Cannara completes Valleyfield building sale for $5.5M | 4 | Stockwatch | ||
| 14.08. | Cannara Biotech Inc.: Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale | 141 | GlobeNewswire (Europe) | MONTREAL, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade... ► Artikel lesen | |
| 30.07. | Cannara Biotech is a buy, Research Capital says | 1 | Cantech Letter | ||
| 28.07. | Almaden, CyberCatch, Cannara Hit 52-Week Highs on News | 3 | Baystreet.ca | ||
| 28.07. | Cannara Biotech meldet starkes Wachstum im dritten Quartal 2025 | 4 | Investing.com Deutsch | ||
| 28.07. | Cannara Biotech Inc Bottom Line Rises In Q3 | 1 | RTTNews | ||
| 28.07. | Cannara Biotech reports Q2 results | 8 | Seeking Alpha | ||
| 24.07. | Cannara Biotech Inc (2): Cannara to sell five vape cartride products in Quebec | 2 | Stockwatch | ||
| 24.07. | Cannara Biotech Inc.: Cannara Secures 5 Key Listings in Québec's New Vape Cartridge Category Including to be Released Live Rosin Vapes | 1 | GlobeNewswire (USA) | ||
| 21.07. | Cannara Biotech Inc (2): Cannara to release Q3 results July 28 | 1 | Stockwatch | ||
| 19.06. | Cannara Biotech Inc (2): Cannara Biotech to hold investor webcast June 25 | 2 | Stockwatch | ||
| 19.06. | Cannara Biotech Inc.: Cannara Biotech to Host Investor Webcast on June 25th, 2025 | 1 | GlobeNewswire (USA) |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 43,560 | -2,80 % | Novo Nordisk: Spannender November in Sicht | Die Aktie von Novo Nordisk tritt derzeit auf der Stelle. In den kommenden Wochen stehen bei den Dänen aber einige wichtige Termine an (vgl. "Novo Nordisk im Umbruch - zwei wichtige Termine voraus").... ► Artikel lesen | |
| AURORA CANNABIS | 4,215 | +1,08 % | Aurora Cannabis Inc.: Aurora Announces Investment into German Manufacturing Facility | NASDAQ| TSX: ACB
Facility investment includes adopting the company's unmatched global manufacturing practices for superior cannabis production and quality
EDMONTON... ► Artikel lesen | |
| CANOPY GROWTH | 1,052 | -2,23 % | Stocks in Play: Canopy Growth Corporation | ||
| STADA ARZNEIMITTEL | - | - | Canson Capital Partners agiert als Federführender Finanzberater von Capvest bei der Akquisition von Stada und co-investiert über seinen Merchant Banking Arm | London (ots/PRNewswire) - STADA ist die sechste Private-Equity-Transaktion, bei der Canson als Finanzberater und Co-Investor auftrittCanson Capital Partners ("Canson") freut sich bekannt zu geben, dass... ► Artikel lesen | |
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 1,112 | +0,50 % | Mehr als "nur" Cannabis-Blüten - Bioxyne setzt auf Produktvielfalt im Wettbewerb mit Tilray, High Tide und Aurora | ||
| INNOCAN PHARMA | 11,000 | -0,90 % | Breaking News: Nur noch fünf Tage für InnoCan Pharma?! | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
| CRONOS GROUP | 2,150 | +1,61 % | Cronos Group Inc: Cronos brings back caramel green apple edible | ||
| SYNBIOTIC | 2,590 | -1,89 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Stellungnahme
SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Agrees to Mutual Termination of Business Combination Agreement with 3Win Corp. and D-3 Merger Sub, Inc. | Vancouver, British Columbia--(Newsfile Corp. - October 29, 2025) - Digicann Ventures Ltd. (CSE: DCNN) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis... ► Artikel lesen | |
| WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
| ORGANIGRAM GLOBAL | 1,360 | -0,73 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| GREEN THUMB INDUSTRIES | 6,005 | +1,52 % | Green Thumb Industries Inc: Green Thumb Industries to release Q3 results Nov. 5 | ||
| SNDL | 1,862 | +0,43 % | SNDL Inc. - 6-K, Report of foreign issuer |
CANNARA BIOTECH INC gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 1,000 Euro und damit -0,99 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANNARA BIOTECH INC finden Sie auf Wallstreet Online.